CRISPR-Cas editing of C. albicans holds promise for overcoming deadly fungal infections
Friday, April 3, 2015 - 13:00
in Biology & Nature
By modifying the CRISPR-Cas genome editing system, Whitehead Institute researchers are now able to manipulate Candida albicans' genome systematically—an approach that could help identify novel targets for therapies against this serious pathogen for which there are a limited number of anti-fungal agents.